Table 1. Demographic and Clinical Characteristics of Respondents.
Variable | DEMQOL | DEMQOL-Proxy | ||
---|---|---|---|---|
United Kingdom (n = 868) | Latin Americaa (n = 417) | United Kingdom (n = 909) | Latin Americab (n = 495) | |
Note. MMSE = Mini-Mental State Examination (Folstein, Folstein, & McHugh, 1975); CDR = Clinical Dementia Rating Scale (C. P. Hughes, Berg, Danziger, Coben, & Martin, 1982). Age differences between United Kingdom and Latin America study samples have small effect sizes for DEMQOL (Hedges’ g = .13) and DEMQOL-Proxy (Hedges’ g = .10). Differences in proportion of male respondents between UK and Latin America study samples have small effect sizes for DEMQOL (Phi = .06) and DEMQOL-Proxy (Phi = .10). Differences in illness severity prevalence between United Kingdom and Latin America study samples have medium effect sizes for DEMQOL (Cramer’s V = .25) and DEMQOL-Proxy (Cramer’s V = .23). | ||||
a Venezuela (n = 53), Peru (n = 70), Cuba (n = 90), Mexico (n = 87), and Dominican Republic (n = 117). b Venezuela (n = 65), Peru (n = 92), Cuba (n = 110), Mexico (n = 103), and Dominican Republic (n = 125). | ||||
Age (SD) | 78.6 (8.5) | 79.7 (7.6) | 78.9 (8.4) | 79.7 (7.7) |
Gender | ||||
Male | 313 | 126 | 340 | 138 |
Female | 555 | 291 | 569 | 357 |
Severity | ||||
Mild | MMSE > 20 | CDR < 2 | MMSE > 20 | CDR < 2 |
517 | 353 | 509 | 392 | |
Moderate | MMSE 15–20 | CDR = 2 | MMSE 15–20 | CDR = 2 |
255 | 50 | 268 | 77 | |
Severe | MMSE < 15 | CDR = 3 | MMSE < 15 | CDR = 3 |
96 | 14 | 132 | 26 |